commercial strategy

News

MSD splits pharma business, hiving off oncology

MSD is separating its cancer and non-cancer pharma operations as it prepares for the looming loss of patent protection for $31bn blockbuster Keytruda.

News

JPM: Novo Nordisk CEO gives insight into new strategy

Novo Nordisk CEO Mike Doustdar covers oral Wegovy, DTC sales channels, and an under-appreciated obesity pipeline in a wide-ranging presentation.

Digital

From weeks to minutes: How AI transforms pharmaceutical mark...

Agentic AI isn’t just another analytical instrument. It represents a reimagining of how strategic intelligence is generated and applied.

Sales & Marketing

Beyond the launch date: Why pharma must rethink readiness fo...

Explore why pharma companies must rethink their NHS strategies post-launch, with tools like IQVIA'S Market Access Launch Pad.

Sales & Marketing

Beyond the vision: Is a 'cultural undertow' drowning your bi...

Biopharma thrives on innovation – pouring billions into R&D to bring transformative therapies to life.

Sales & Marketing

The exponential imperative: Rethinking biopharma strategy fo...

The biopharma industry – long a powerhouse of scientific innovation – now stands at a critical inflection point.

MSD splits pharma business, hiving off oncology

JPM: Novo Nordisk CEO gives insight into new strategy

From weeks to minutes: How AI transforms pharmaceutical mark...

Beyond the launch date: Why pharma must rethink readiness fo...

Beyond the vision: Is a 'cultural undertow' drowning your bi...

The exponential imperative: Rethinking biopharma strategy fo...

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

commercial strategy

Editor's Picks